February 6, 2024
Avalyn to Participate in Multiple Upcoming Investor Conferences
December 6, 2023
Avalyn to Participate in the 2023 RBC Capital Markets Healthcare Private Company Conference
November 9, 2023
Avalyn Presents Data from its AP01 and AP02 Inhaled Therapeutics Programs for Pulmonary Fibrosis
September 29, 2023
Avalyn to Provide Keynote Presentation at the Formulation & Delivery U.S. 2023 Conference
September 27, 2023
September 18, 2023
Avalyn Pharma’s CEO Leads Workshop on Clinical Strategy at IPF Summit
September 12, 2023
September 11, 2023
September 7, 2023
August 7, 2023
June 15, 2023
May 10, 2023